[1] WANG L, PENG W, ZHAO Z, et al. Prevalence and Treatment of Diabetes in China, 2013-2018 [J]. JAMA, 2021, 326(24): 2498-506.
[2] ZHANG M, SHI Y, ZHOU B, et al. Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey [J]. BMJ, 2023, 380: e071952.
[3] World Health Organization. Noncommunicable diseases [EB/OL].[2023-09-19] [2024-02-15] .https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases.
[4] Institute for Health Metrics and Evaluation. GBD Compare [EB/OL]. (2020-10-15) [2024-02-15] .https://vizhub.healthdata.org/gbd-compare/.
[5] 中国疾病预防控制中心慢性非传染性疾病预防控制中心.中国慢性病及危险因素监测报告 2018[M]. 北京:人民卫生出版社,2021:1-300.